M. Matsui et al.
Bull. Chem. Soc. Jpn., 76, No. 7 (2003) 1407
(S)- and (R)-Flurbiprofens, (R,S)- and (R,R)-7, were observed
at retention times of around 130 and 140 min, respectively.
The retention time of the (R,S) derivative was checked by
comparing that of the product obtained by the reaction of
(S)-5 with 3. The ratio between (R,S)- and (R,R)-7 was 55.8
to 44.2. Several pmol of racemic Flurbiprofens could be ana-
lyzed by this method.
Conclusion
An enantiomeric fluorescent labeling reagent for carboxylic
acids was prepared from Rhodamine B. The absorption and
emission maxima of this reagent was observed at ꢀ 557 and
580 nm in an acetonitrile–acetic acid (9:1) mixed solution,
respectively. Racemic Flurbiprofen smoothly reacted with this
reagent in the presence of EDC to produce the corresponding
diastereomeric esters, which were separated by non-chiral
HPLC.
Fig. 4. Effect of water on fluorescence intensity of 4, 8, and
9 (1 ꢂ 10ꢁ5 mol dmꢁ3). In the cases of 8 and 9, the ab-
scissa indicates the % ratio of (H2O/(H2O + MeCN)).
Experimental
Apparatus. Melting points were measured with a Yanagimoto
MP-S2 micro-melting-point apparatus. NMR spectra were taken
on a Jeol ꢁ-400 spectrometer. EIMS spectra were recorded on a
Shimadzu QP-1000 instrument. UV-vis and fluorescence spectra
were measured with Hitachi U-3500 and F-4500 spectrometers,
respectively. HPLC was performed with a Jeol Triroter-V instru-
ment.
Materials.
Rhodamine B (1) was purchased from Tokyo
Kasei Co., Ltd. (R)-(ꢁ)-2-Amino-1-propanol (2) was obtained
from ACROS Organics. Racemic and (S)-Flurbiprofens were pur-
chased from Aldrich Co., Ltd.
Synthesis of 3. To Rhodamine B (1) (120 mg, 0.25 mmol) was
added (R)-(ꢁ)-2-amino-1-propanol (2) (500 mg, 6.67 mmol). The
mixture was heated at 170 ꢃC for 24 h. After the reaction was
completed, the mixture was poured into brine. The product was
extracted with dichloromethane and recrystallized from ethyl
ꢃ
1
acetate. (106 mg, 79%). Mp 258.5–259.0 C; H NMR (CDCl3)
ꢂ 1.10 (d, J ¼ 7:1 Hz, 3H), 1.165 (t, J ¼ 7:1 Hz, 6H), 1.171 (t,
J ¼ 7:1 Hz, 6H), 3.21–3.24 (m, 1H), 3.34 (q, J ¼ 7:1 Hz, 4H),
3.35 (q, J ¼ 7:1 Hz, 4H), 3.48 (ddd, J ¼ 11:7, 8.7, and 4.6 Hz,
1H, a doublet peak (J ¼ 8:7 Hz) disappears in the presence of
D2O), 3.55 (d, J ¼ 11:7 Hz, 1H), 5.03 (d, J ¼ 8:7 Hz, 1H, dis-
appeared in the presence of D2O), 6.27–6.30 (m, 2H), 6.37 (dd,
J ¼ 9:5 and 2.8 Hz, 2H), 6.47 (dd, J ¼ 9:5 and 4.1 Hz, 2H), 7.05–
7.08 (m, 1H), 7.44–7.48 (m, 2H), 7.87–7.90 (m, 1H); EIMS (70
Fig. 5. HPLC analysis of labeled diastereomeric (R,S)- and
(R,R)-7. Column: Mightysil RP-18 GP (4.6 mm ꢂ 150
mm); Mobile phase: acetonitrile–tetrahydrofuran–0.5%
acetic acid (28:5:67); Flow rate: 0.8 cm3 minꢁ1; Excita-
tion: 562 nm, Detection: 582 nm.
25
eV) m=z (rel intensity) 499 (Mþ; 18), 469 (42), 468 (100). [ꢁ]D
(c ¼ 0:0455, CHCl3) ꢁ52:7ꢃ. Anal. Found: C, 74.23; H, 7.66; N,
8.13%. Calcd for C31H37N3O3: C, 74.52; H, 7.46; N, 8.41%.
HPLC Analysis of Racemic Flurbiprofens (5). To a dichlo-
romethane solution (0.6 cm3) of racemic Flurbiprofens 5 (1.2
mmol) were added a dichloromethane solution (0.6 cm3) of 4-(1-
pyrrolidinyl)pyridine (10 mmol dmꢁ3, 6 mmol), a dichloromethane
solution (0.6 cm3) of 3 (10 mmol dmꢁ3, 6 mmol), a dichloro-
methane solution (0.6 cm3) of EDC (10 mmol dmꢁ3, 6 mmol),
and aflatoxin G2 (10 mg dmꢁ3). Aflatoxin G2 was used as a
reference compound in the HPLC analysis. The mixture reacted
in a vial tube at 20 ꢃC for 7 h. After drying the reaction mixture, 2
cm3 of an acetonitrile–0.5% acetic acid (55:45) mixed solution
was added. The solution was then analyzed by HPLC (column:
Mightysil RP18 GP (4.6 mm ꢂ 150 mm); mobile phase: aceto-
nitrile–tetrahydrofuran–0.5% aqueous acetic acid (28:5:67), flow
rate: 0.8 cm3 minꢁ1; excitation: 562 nm, detection: 582 nm).
as a good fluorescent labeling reagent.
Finally, racemic Flurbiprofens (5), which acts as inhibitors
for cyclooxygenase, reacted with 3 in the presence of 4-(1-
pyrrolidinyl)pyridine and 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (EDC) to produce diastereo-
meric esters (R,R)- and (R,S)-6, which reacted with acetic acid
to form the corresponding open forms of (R,S)- and (R,R)-7, as
shown in Scheme 1. When an acetonitrile–acetic acid (9:1)
mixed solvent was used as a mobile phase, no good separation
of the diastereomers in HPLC was observed. Therefore, after
the formation of open-forms 7, the diastereomers were ana-
lyzed by HPLC. An acetonitrile–tetrahydrofuran–aqueous
0.5% acetic acid (28:5:67) mixed solvent was used as a mobile
phase. The HPLC analysis of racemic Flurbiprofens (5) is
shown in Fig. 5. The labeled diastereomers derived from